Valone F H
Veterans Administration Medical Center, Cancer Research Institute, San Francisco, CA 94121.
J Immunol. 1988 Apr 1;140(7):2389-94.
Platelet-activating factor (PAF) binding and metabolism by eight murine and human cell lines was analyzed. Only the murine P388D1 macrophage line had specific, high affinity PAF binding sites. PAF binding reached saturation within 10 min at room temperature and was irreversible. Minimal PAF metabolism was observed at the time binding saturation was achieved. Scatchard analysis of PAF binding revealed a single class of PAF receptors (7872 +/- 1310/cell) which had a dissociation constant of 0.08 +/- 0.01 nM (mean +/- SEM, eta = 6). The dissociation constant was confirmed independently by quantifying the kinetics of initial specific PAF binding. PAF binding was stereospecific, required an sn-2 acetyl substituent, and was inhibited by structurally diverse PAF antagonists including kadsurenone, BN 52021, triazolam, and CV3988. The fact that the receptors are functionally active was shown by the observation that 1 to 100 pM PAF increased free intracellular calcium in P388D1 cells in a dose-related manner. These studies demonstrate that P388D1 macrophages have functional PAF receptors whose affinity and structural specificities are similar to PAF receptors in other cells. The availability of a stable cell line that binds but does not metabolize PAF will greatly facilitate studies of the PAF receptor.
分析了8种鼠类和人类细胞系对血小板活化因子(PAF)的结合及代谢情况。只有鼠类P388D1巨噬细胞系具有特异性、高亲和力的PAF结合位点。PAF结合在室温下10分钟内达到饱和且不可逆。在结合达到饱和时观察到PAF的代谢极少。对PAF结合进行Scatchard分析显示存在一类单一的PAF受体(7872±1310/细胞),其解离常数为0.08±0.01 nM(均值±标准误,n = 6)。通过对初始特异性PAF结合动力学进行定量分析,独立证实了解离常数。PAF结合具有立体特异性,需要sn-2位乙酰取代基,并且受到包括海风藤酮、BN 52021、三唑仑和CV3988等结构多样的PAF拮抗剂的抑制。观察到1至100 pM的PAF以剂量相关方式增加P388D1细胞内游离钙,这表明这些受体具有功能活性。这些研究表明,P388D1巨噬细胞具有功能性PAF受体,其亲和力和结构特异性与其他细胞中的PAF受体相似。一种能够结合但不代谢PAF的稳定细胞系的存在将极大地促进对PAF受体的研究。